fix: correct 4-hydroxy-13-cis-retinoate (misnamed 4-oxo) and merge duplicate#1044
Open
edkerk wants to merge 2 commits into
Open
fix: correct 4-hydroxy-13-cis-retinoate (misnamed 4-oxo) and merge duplicate#1044edkerk wants to merge 2 commits into
edkerk wants to merge 2 commits into
Conversation
…plicate (#375) MAM01026 and MAM00348 were near-duplicate metabolites named as the 4-oxo 13-cis form, but they are actually 4-hydroxy-13-cis-retinoate: their formula (C20H27O3) is the 4-hydroxy formula (matching 4-hydroxy-all-trans- retinoate MAM00993 and DrugBank DBMET02554), while the true 4-oxo forms (all-trans MAM01031, 9-cis MAM01029) are C20H25O3; and every reaction that makes them (MAR06681/06682/08703/08706) is a hydroxylation that adds one O without removing H. So the name and cross-references were wrong, not the formula (changing the formula to 4-oxo would have unbalanced all four reactions). - Merge MAM00348 into MAM01026 and rename to 4-hydroxy-13-cis-retinoate; keep formula C20H27O3. - Remove the incorrect 4-oxo MetaNetX cross-references (MNXM37697, MNXM6902, MNXM146866). - Fix MAR08703 so all-trans-retinoate is hydroxylated to the all-trans product (MAM00993), not the 13-cis form. - Remove MAR08704 (interconversion of the two duplicates, trivial after the merge) and MAR01564 (duplicate nuclear transport of MAR01563). MAM00348 and the removed reactions are moved to the deprecated lists. All modified reactions remain mass and charge balanced. The true 4-oxo-13-cis-retinoate (the major isotretinoin metabolite) is not present in the model; adding it with the 4-hydroxy -> 4-oxo step (mirroring the all-trans pathway MAR06702/06703) would be a good follow-up.
|
This PR has been automatically tested with GH Actions. Here are the results of the quality-control tests: MACAW: dead-end and duplicate testsMass and charge balanceMore detailed output is committed to
|
This file contains hidden or bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Sign up for free
to join this conversation on GitHub.
Already have an account?
Sign in to comment
Add this suggestion to a batch that can be applied as a single commit.This suggestion is invalid because no changes were made to the code.Suggestions cannot be applied while the pull request is closed.Suggestions cannot be applied while viewing a subset of changes.Only one suggestion per line can be applied in a batch.Add this suggestion to a batch that can be applied as a single commit.Applying suggestions on deleted lines is not supported.You must change the existing code in this line in order to create a valid suggestion.Outdated suggestions cannot be applied.This suggestion has been applied or marked resolved.Suggestions cannot be applied from pending reviews.Suggestions cannot be applied on multi-line comments.Suggestions cannot be applied while the pull request is queued to merge.Suggestion cannot be applied right now. Please check back later.
Main improvements in this PR:
Resolves #375. MAM01026 and MAM00348 were near-duplicate metabolites named as the 4-oxo-13-cis form, but an adversarial review against PubChem/DrugBank and the reactions shows they are actually 4-hydroxy-13-cis-retinoate:
Changes:
4-hydroxy-13-cis-retinoate(formula C20H27O3 kept).MAM00348 and the removed reactions are in the deprecated lists. All modified reactions remain mass and charge balanced; no genes orphaned. The true 4-oxo-13-cis-retinoate (major isotretinoin metabolite) is not represented and could be added with the 4-hydroxy -> 4-oxo step as a follow-up.
I hereby confirm that I have:
developas a target branch